IZP 94005
Alternative Names: Contignasterol; PneumocortLatest Information Update: 02 Aug 2004
At a glance
- Originator Inflazyme Pharmaceuticals
- Class Antiallergics; Antiasthmatics; Antihistamines; Antirheumatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 02 Aug 2004 Discontinued - Preclinical for Asthma in Canada (unspecified route)
- 02 Aug 2004 Discontinued - Preclinical for Asthma in United Kingdom (unspecified route)
- 11 Jun 1999 No-Development-Reported for Asthma in Canada (Unknown route)